Health Care Consultants Publish Research on the Economic Burden of Diabetic Foot Ulcers
March 25, 2014
Treating patients with diabetic foot ulcers (DFU) adds substantial costs of care compared to treating patients with diabetes alone, according to a recent study conducted by a team of researchers from Analysis Group and Organogenesis. The study, "Burden of Diabetic Foot Ulcers for Medicare and Private Insurers" (Diabetes Care, March 2014), estimated the annual, incremental, per-patient burden that treating DFU places on public and private payers. The researchers, including Manager Brad Rice and Principal Howard Birnbaum, estimated that DFU imposes an annual burden on public and private payers ranging from $9 billion to $13 billion, in addition to the costs associated with diabetes itself. Additional costs for treating DFU include hospitalizations, home health care, and emergency room and physician office visits.
Dr. Rice discussed the study in the recent Medscape Medical News article "Huge Burden of Foot Ulcers Doubles Diabetes Costs in U.S." (March 13, 2014). "Patients with diabetic foot ulcers can require considerable amounts of health care resources, but little is known about the burden of diabetic foot ulcers imposed on the U.S. health care system and payers," explained Dr. Rice. "We hope these findings will raise awareness of the costs associated with this condition."
Read the study abstract
Read the article (subscription required)